HOME - Clinical cases - Oral pathology
 
 
05 August 2025

Update on molecular pathology in oral cancer and precancer


Oral carcinogenesis is a multifactorial process involving numerous genetic events that alter normal functions of oncogenes and tumour suppressor genes.

This may increase the production of growth factors or the number of receptors on the cell surface, and/or increase transcription factors or intracellular signal messengers.

Together with the loss of tumour suppressor activity, these changes lead to a cell phenotype that can increase cell proliferation, with loss of cell cohesion, and infiltration of adjacent tissue thus causing distant metastasis. Molecular pathology is responsible for defining the molecular mechanisms that underlie the onset of oral precancer and cancer.

The aim of this review is to describe recent advances in our understanding of the molecular control of the innumerable pathways related to these processes. These may lead to short- or medium term improvements in the diagnosis and prognosis of oral precancerous and cancerous lesions and to the development of novel therapeutic approaches to this disease.


Authors: J. CAMPO-TRAPERO, J. CANO-SÁNCHEZ, B. PALACIOS-SÁNCHEZ, JJ. SÁNCHEZ-GUTIERREZ, M.A. GONZÁLEZ-MOLES and A. BASCONES-MARTÍNEZ

Source: https://ar.iiarjournals.org/

Related articles

Garrison Dental Solutions has announced important enhancements to its Quad Matrix System with the release of updated Quad Wedges, building on the system’s strong clinical adoption for complex Class...


DEXIS™, a global leader in dental imaging, today introduced its most advanced update yet to the DTX Studio™ platform—bringing AI-driven diagnostics and multi-site connectivity designed to...


To update the findings of a systematic review from the year 2016 on the evidence for the accuracy and potential benefits of cone beam computed tomography (CBCT) in periodontal diagnostics.


New surgical kits, a 6.0-mm implant, and upgraded accessories elevate the clinical ease and versatility of the company’s flagship system.


Envista Holdings Corporation (NYSE: NVST) (“Envista”) will report financial results for its fourth quarter 2024 on Wednesday, February 5, 2025. 


Read more

You may have noticed that more and more of your patients have started seeking toothpastes that are free of Sodium Lauryl Sulfate (SLS).


Multi-segment series highlights how oral health connects to overall health and why connected care matters


The New York State Dental Association (NYSDA) today called on state lawmakers to reject proposed reductions to the pass-through entity tax (PTET) credit


Graduating students presented research spanning artificial intelligence, clinical care, and global health 


 
 
 
 

 
 
 
 

Most popular

 
 

Events